Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers

被引:56
作者
Asthana, Asha [1 ]
Johnson, Heather M. [1 ]
Piper, Megan E. [1 ]
Fiore, Michael C. [1 ]
Baker, Timothy B. [1 ]
Stein, James H. [1 ]
机构
[1] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53792 USA
关键词
C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; SUSTAINED-RELEASE BUPROPION; RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR RISK-FACTORS; RECEPTOR PARTIAL AGONIST; MYOCARDIAL-INFARCTION; CIGARETTE-SMOKING; LIFE-STYLE; PLACEBO;
D O I
10.1016/j.ahj.2010.06.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Cigarette smoking has been associated with increases in C-reactive protein (CRP) and leukocyte counts (white blood cell [WBC]); however, the effects of smoking intensity and smoking cessation on inflammatory markers have not been evaluated prospectively in a large, modern cohort of current smokers. Methods White blood cell count and high-sensitivity CRP were measured in current smokers enrolled in a randomized, prospective clinical trial of 5 smoking cessation pharmacotherapies. Smoking intensity parameters included cigarettes per day, pack-years, Fagerstrom Test of Nicotine Dependence score, and carbon monoxide levels. C-reactive protein also was measured after 1 year with assessment of abstinence status. Results The 1,504 current smokers (58% female) were (mean [SD]) 44.7 (11.1) years old, smoked 21.4 (8.9) cigarettes per day, and had a smoking burden of 29.4 (20.4) pack-years. Log(CRP) was not associated with any marker of smoking intensity, except for a weak correlation with pack-years (r = 0.05, P = .047). In contrast, statistically significant correlations were observed between all 4 markers of smoking intensity and WBC count (all P <= .011). In multivariable models, waist circumference (P < .001) and triglycerides (P < .05), but no markers of smoking intensity, were associated with log(CRP). However, pack-years (P = .002), cigarettes per day (P = .013), carbon monoxide (P < .001), and Fagerstrom Test of Nicotine Dependence (P < .001) were independently associated with WBC count. After 1 year, log(CRP) (P = .296) and changes in log (CRP) (P = .455) did not differ between abstainers and continuing smokers. Conclusions Smoking intensity is associated with increased WBC count, but not CRP levels. Smoking cessation does not reduce CRP. The relationship between CRP and smoking intensity may be masked by CRP's stronger relationship with adiposity. (Am Heart J 2010;160:458-63.)
引用
收藏
页码:458 / 463
页数:6
相关论文
共 28 条
  • [1] Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States
    Bazzano, LA
    He, J
    Muntner, P
    Vupputuri, S
    Whelton, PK
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 138 (11) : 891 - 897
  • [2] Rotation between markers of systemic vascular inflammation and smoking in women
    Bermudez, EA
    Rifai, N
    Buring, JE
    Manson, JE
    Ridker, PM
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (09) : 1117 - +
  • [3] Psychological risk factors and the metabolic syndrome in patients with coronary heart disease: Findings from the Heart and Soul Study
    Cohen, Beth E.
    Panguluri, Praveen
    Na, Beeya
    Whooley, Mary A.
    [J]. PSYCHIATRY RESEARCH, 2010, 175 (1-2) : 133 - 137
  • [4] International physical activity questionnaire:: 12-country reliability and validity
    Craig, CL
    Marshall, AL
    Sjöström, M
    Bauman, AE
    Booth, ML
    Ainsworth, BE
    Pratt, M
    Ekelund, U
    Yngve, A
    Sallis, JF
    Oja, P
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2003, 35 (08) : 1381 - 1395
  • [5] Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies
    Danesh, J
    Collins, R
    Appleby, P
    Peto, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18): : 1477 - 1482
  • [6] Mortality in relation to smoking: 50 years' observations on male British doctors
    Doll, R
    Peto, R
    Boreham, J
    Sutherland, I
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7455): : 1519 - 1528
  • [7] Freund K M, 1993, Ann Epidemiol, V3, P417, DOI 10.1016/1047-2797(93)90070-K
  • [8] Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation -: A randomized controlled trial
    Gonzales, David
    Rennard, Stephen I.
    Nides, Mitchell
    Oncken, Cheryl
    Azoulay, Salomon
    Billing, Clare B.
    Watsky, Eric J.
    Gong, Jason
    Williams, Kathryn E.
    Reeves, Karen R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (01): : 47 - 55
  • [9] Smoking intensity and lipoprotein abnormalities in active smokers
    Gossett, Linda K.
    Johnson, Heather M.
    Piper, Megan E.
    Fiore, Michael C.
    Baker, Timothy B.
    Stein, James H.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2009, 3 (06) : 372 - 378
  • [10] Socioeconomic Status and Improvements in Lifestyle, Coronary Risk Factors, and Quality of Life: The Multisite Cardiac Lifestyle Intervention Program
    Govil, Sarah R.
    Weidner, Gerdi
    Merritt-Worden, Terri
    Ornish, Dean
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2009, 99 (07) : 1263 - 1270